James D. Carey - Jun 3, 2022 Form 4 Insider Report for HireRight Holdings Corp (HRT)

Role
Director
Signature
/s/ Brian Copple, as Attorney-in-Fact, for James D. Carey
Stock symbol
HRT
Transactions as of
Jun 3, 2022
Transactions value $
$22,241,362
Form type
4
Date filed
6/21/2022, 02:00 PM
Previous filing
Jun 6, 2022
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRT Common Stock, par value $0.001 per share Purchase $448K +30K +0.18% $14.94 16.9M Jun 3, 2022 See footnote F1, F2, F3, F4, F5
transaction HRT Common Stock, par value $0.001 per share Purchase $125K +8.33K +0.05% $15.00 16.9M Jun 9, 2022 See footnote F2, F3, F4, F5, F6
transaction HRT Common Stock, par value $0.001 per share Purchase $1.92M +129K +0.76% $14.87 17.1M Jun 10, 2022 See footnote F2, F3, F4, F5, F7
transaction HRT Common Stock, par value $0.001 per share Purchase $7.53M +513K +3.01% $14.67 17.6M Jun 13, 2022 See footnote F2, F3, F4, F5, F8
transaction HRT Common Stock, par value $0.001 per share Purchase $2.35M +163K +0.93% $14.39 17.7M Jun 14, 2022 See footnote F2, F3, F4, F5, F9
transaction HRT Common Stock, par value $0.001 per share Purchase $2.89M +193K +1.09% $14.96 17.9M Jun 14, 2022 See footnote F2, F3, F4, F5, F10
transaction HRT Common Stock, par value $0.001 per share Purchase $6.98M +468K +2.61% $14.92 18.4M Jun 16, 2022 See footnote F2, F3, F4, F5, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $14.85 to $14.99, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F2 Includes 4,342 shares of the Common Stock held by Mr. Carey solely for the benefit of Stone Point Capital LLC (Stone Point), of which Mr. Carey is a managing director. Mr. Carey disclaims beneficial ownership of these shares of Common Stock, except to the extent of any pecuniary interest therein. Stone Point may be deemed an indirect owner of these shares of Common Stock.
F3 Shares of Common Stock are held by Trident VII, L.P., Trident VII Parallel Fund, L.P., Trident VII DE Parallel Fund, L.P. and Trident VII Professionals Fund, L.P. (the "Trident VII Partnerships"). Trident Capital VII, L.P. ("Trident VII GP") is the general partner of Trident VII, L.P., Trident VII Parallel Fund, L.P. and Trident VII DE Parallel Fund, L.P., and Stone Point GP Ltd. is the general partner of Trident VII Professionals Fund, L.P.
F4 Pursuant to certain management agreements, Stone Point Capital LLC, the investment manager of the Trident VII Partnerships, has received delegated authority by Trident VII GP relating to the Trident VII Partnerships, provided that the delegated discretion to exercise voting rights may not be exercised on behalf of any of the Trident VII Partnerships without first receiving direction from the Investment Committee of the Trident VII GP or a majority of the general partners of the Trident VII GP. Mr. Carey as a member of the investment committee and owner of one of the five general partners of Trident Capital VII, L.P., may be deemed to be the beneficial owner of the securities held directly by the Trident VII Partnerships.
F5 Mr. Carey disclaims beneficial ownership of the shares of Common Stock held of record or beneficially by the Trident VII Partnerships, except to the extent of any pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities and Exchange Act of 1934 or otherwise, Mr. Carey is the beneficial owner of any securities reported herein.
F6 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $14.98 to $15.00, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F7 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $14.50 to $14.99, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F8 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $14.08 to $14.95, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F9 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $13.75 to $14.745, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F10 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $14.75 to $14.99, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F11 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $14.625 to $14.99, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.